This post was originally published on this site
MARKETWATCH FRONT PAGE
BioNTech and Pfizer Inc.’s COVID-19 vaccine candidate is the first to demonstrate it can protect most people from contracting symptomatic infections with the virus in a Phase 3 clinical trial — an announcement that puts the companies in the lead to bring to market the first COVID-19 vaccine in the U.S. See full story.
Dow surges over 1,000 points near record on coronavirus vaccine report
U.S. stocks soar in early trading Monday after Germany-based BioNTech SE and Pfizer Inc. says their COVID-19 vaccine candidate achieved “success” in the first interim analysis of a Phase 3 study. See full story.
Biden has a climate-change mandate — what can he actually achieve?
Joe Biden wavered on the controversial practice of oil and gas fracking early in the campaign but by the time the presumptive president-elect addressed the American people on Saturday night, his interest in a strong U.S. role in the climate-change fight was clearer. See full story.
Why Kamala Harris as America’s first female vice president ‘completely disrupts the status quo’
‘She is poised to not just put really big cracks in that glass ceiling in this election, but she’s poised to break the glass ceiling in a future election.’ See full story.
Reports of the 60/40 stock-bond portfolio’s death are greatly exaggerated
Bonds’ ability to cushion volatility is greater when interest rates are lower. See full story.
MARKETWATCH PERSONAL FINANCE
A member of the Texas Emergency Management Advisory Group estimates that 2 in 15 students will be heading back to their town or city as asymptomatic carriers of the coronavirus. See full story.
